Platinum Industries Subsidiary Inks Exclusive India Deal with Korea’s CAREGEN
Platinum Industries subsidiary Rivadu Lifesciences enters exclusive India deal with Korea's CAREGEN for Korglutide; parent TTM revenue stands at ₹443.99 Cr.
ALFA News
Straight from the exchange filing
Platinum Industries subsidiary Rivadu Lifesciences enters exclusive India deal with Korea's CAREGEN for Korglutide; parent TTM revenue stands at ₹443.99 Cr.